1963
DOI: 10.1002/jps.2600520603
|View full text |Cite
|
Sign up to set email alerts
|

Pharmaceutical Aerosols

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

1969
1969
2002
2002

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 23 publications
(7 citation statements)
references
References 51 publications
0
7
0
Order By: Relevance
“…Particles between 0.5 and 5.0 pm tend to fall against the alveolar walls and mix with the alveolar fluid (162). It is generally agreed that particles larger than 20 pm fail to go beyond the terminal bronchioles, those 6 pm in diameter are removed before they reach the lower alveolar ducts, and almost all particles 2 pm and larger are removed in the lower alveolar ducts (163). There is only a 50% chance for the deposition of particles 1 pm in size.…”
Section: Testing Of Aerosol Productsmentioning
confidence: 99%
“…Particles between 0.5 and 5.0 pm tend to fall against the alveolar walls and mix with the alveolar fluid (162). It is generally agreed that particles larger than 20 pm fail to go beyond the terminal bronchioles, those 6 pm in diameter are removed before they reach the lower alveolar ducts, and almost all particles 2 pm and larger are removed in the lower alveolar ducts (163). There is only a 50% chance for the deposition of particles 1 pm in size.…”
Section: Testing Of Aerosol Productsmentioning
confidence: 99%
“…Those larger than 6 µm fail to reach the alveolar ducts. The optimum particle size to reach and be deposited in the alveolar region seems to be 1 to 5 µm (70,71,74,75). Submicrometer-size particles are exhaled, deposited, or both by random Brownian motion in distal regions.…”
Section: Mass Median Aerodynamic Diametermentioning
confidence: 99%
“…When insulin dry powder containing 0.036 mg/dose of citric acid was administered to rat lungs, bronchoalveolar lavage was as low as that for saline administration, suggesting that citric acid is a safe additive (36). Adding an 74 KONA No. absorption enhancer is a promising method for increasing the systemic bioavailability of inhaled peptides and proteins, but long-term safety should be examined for application to humans.…”
Section: Additives For Improving Bioavailability Of Inhaled Peptides mentioning
confidence: 99%
See 1 more Smart Citation
“…BACKGROUND Extensive research (3) has been conducted on the relationship of the particle size of an active drug to its distribution and retention in the lungs. The conflict of theories and experimental results has been attributed to such variables as the species of animal used, nonuniform breathing rates, methods of measuring the particle-size distribution, methods of administering the agents used, and the effects of lung moisture content on the size of the inhaled particles (4)(5)(6). However, it generally is agreed that the depth of penetration increases with decreasing particle size while the whole lung retention increases with increasing particle size (7,8).…”
mentioning
confidence: 99%